Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. (PANNA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Radboud University
PENTA Foundation
Merck Sharp & Dohme Corp.
Bristol-Myers Squibb
Janssen Pharmaceutica
ViiV Healthcare
Information provided by (Responsible Party):
Radboud University Identifier:
First received: January 19, 2009
Last updated: September 15, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2020
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):